Yale and Mayo Clinic Clinical Translational Science Award Linked Collaborative Project
Mayo Clinic Center for Translational Science Activities (CTSA) and Yale Center for Clinical Investigation (YCCI) partnered on a linked collaborative project, which:
- Exchanged best practices and resources for the benefit of research support
- Shared findings for possible implementation at Centers for Translational Science Awards institutions
- Was funded by linked American Reinvestment and Recovery Act supplement grants
This linked collaborative between the Mayo Clinic Center for Translational Science Activities (CTSA) and the Yale Center for Clinical Investigation (YCCI) explored opportunities to exchange best practices, administrative and regulatory support models, and related infrastructure supporting clinical research to minimize barriers to the initiation of research and provide timely access to exceptional support resources for our investigative faculty.
- Identify and assess feasibility of potential areas of collaboration that leverage the unique strengths of Mayo Clinic CTSA and the Yale CTSA in the initiation and support of research protocols.
- Develop and implement a collaboration model(s) for the sharing of specific best practices, expertise and technologies between Mayo Clinic CTSA and YCCI.
- Disseminate the project findings and any possible “shared” tools/processes to the CTSA consortium members.
During the first two face-to-face meetings, a series of potential projects were critically reviewed. From these, a list of initial projects was identified as consensus priorities with several additional projects to be explored at subsequent meetings - time and resources permitting.
Five projects were considered to be within the Strategic Goal Committee primary scope: To improve all processes related to the development, approval, activation, enrollment and completion of clinical trials. Several components within these projects were determined to be outside of the scope of this supplement. Given the interest of Mayo Clinic CTSA and YCCI as to their potential benefit, these project components will be pursued separately and independent of this supplement.
Project coordination was via an oversight group via monthly teleconferences. Members included the YCCI chief operating officer and associate director; and the Mayo Clinic CTSA director of administration and associate director of administration, as well as physician leaders when necessary.
Agenda items included progress on agreed milestones and deliverables, coordination of face-to-face meetings and communication with CTSA leadership. Project teams also held regular teleconferences. There were numerous face-to-face meetings on each campus, which the groups felt were extremely beneficial to advancing the projects and relationships.
One of the first milestones was drafting and receiving legal approval from each institution for a license agreement to begin the work.
After the first year, Mayo Clinic CTSA and YCCI presented interim results for two projects at a Regional Clinical Research Management Workshop sponsored by YCCI on February 22, 2011, in New Haven, Conn.
In June 2011, four posters were shared and the overall collaborative model was presented as a session for all attendees at the national Clinical Research Management Workshop in Bethesda, Maryland.
Project oversight and administration
Projects and lead contacts
The linked collaborative project sponsored the following initiatives:
Comparing Solutions for Simple Process Improvement: Mayo ACTION Cancer Center Project and Yale Carpedia Cancer Center Project
Education Protocols: Exportability of Yale/Mayo Clinic Content
Developing Community-Placed Resources to Engage Minority Participation in Research
Sharing Resources for Regulatory Services and Support
Analysis of Protocol Handling and Review to Decrease Initial Protocol Review Time